CN102688356A - Chinese medicinal oral liquid for easing Qi-deficiency type coronary disease and preparation method - Google Patents
Chinese medicinal oral liquid for easing Qi-deficiency type coronary disease and preparation method Download PDFInfo
- Publication number
- CN102688356A CN102688356A CN2012102086563A CN201210208656A CN102688356A CN 102688356 A CN102688356 A CN 102688356A CN 2012102086563 A CN2012102086563 A CN 2012102086563A CN 201210208656 A CN201210208656 A CN 201210208656A CN 102688356 A CN102688356 A CN 102688356A
- Authority
- CN
- China
- Prior art keywords
- parts
- oral liquid
- deficiency type
- heart disease
- coronary heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 42
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 14
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 14
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 11
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 11
- 241001522129 Pinellia Species 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 5
- 239000003814 drug Substances 0.000 claims description 33
- 238000009835 boiling Methods 0.000 claims description 20
- 210000000582 semen Anatomy 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 15
- 241000218628 Ginkgo Species 0.000 claims description 13
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 241000545442 Radix Species 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 208000024891 symptom Diseases 0.000 abstract description 13
- 208000002193 Pain Diseases 0.000 abstract description 6
- 230000002269 spontaneous effect Effects 0.000 abstract description 3
- 206010033557 Palpitations Diseases 0.000 abstract description 2
- 208000000059 Dyspnea Diseases 0.000 abstract 1
- 206010013975 Dyspnoeas Diseases 0.000 abstract 1
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 206010051602 Laziness Diseases 0.000 abstract 1
- 208000019914 Mental Fatigue Diseases 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 206010042727 Swollen tongue Diseases 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 206010016256 fatigue Diseases 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 208000013220 shortness of breath Diseases 0.000 abstract 1
- 230000003203 everyday effect Effects 0.000 description 8
- 206010002383 Angina Pectoris Diseases 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 210000000038 chest Anatomy 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 5
- 206010061876 Obstruction Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 3
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000009912 gualou xiebai baijiutang Substances 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 238000007373 indentation Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 241000227129 Aconitum Species 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000015943 Coeliac disease Diseases 0.000 description 1
- 206010009866 Cold sweat Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008563 guizhi decoction Substances 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 208000023482 precordial pain Diseases 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal oral liquid for easing a Qi-deficiency type coronary disease and a preparation method. The Chinese medicinal oral liquid is prepared from the following raw medicinal materials in parts by weight: 200-400 parts of red sage root, 200-400 parts of astragalus root, 100-200 parts of folium ginkgo, 50-120 parts of stigma croci, 50-120 parts of cassia seed, 100-200 parts of pinellia tuber, 150-200 parts of poria cocos, and 50-100 parts of liquorice. The Chinese medicinal oral liquid provided by the invention is used for rapidly easing the Qi-deficiency type coronary disease with the main symptom of dull pain and other symptoms, such as attack due to fatigue, mental fatigue,, shortness of breath and laziness to speak, palpitation and spontaneous perspiration, dim tongue nature, swollen tongue, teeth-printed tongue edge, white and smooth tongue moss and weak pulse, is specially prepared for a specific purpose, and is effective in treatment.
Description
Technical field
The invention belongs to the field of Chinese medicines, particularly a kind of alleviation qi-deficiency type coronary heart disease Chinese medicine oral liquid and method for preparing.
Background technology
Coronary heart disease, promptly coronary atherosclerotic heart disease is called ischemic heart desease again.What be meant that coronary atherosclerosis causes is a kind of heart disease of Clinical symptoms with myocardial ischemia, anoxia.Primary disease is sent out well in the middle-aged and elderly people more than 40 years old, and the male is more than the women, and is in the majority with the brain worker.The traditional Chinese medical science is categories such as " chest pain ", " thoracic obstruction ", " pained ", " angina pectoris ", " precordial pain with cold limbs "." Medical Treasures of the Golden Chamber obstruction of qi in the chest and cardialgia lose heart abnormal pulse card control a piece of writing " proposed the sick pathogenesis of obstruction of qi in the chest and cardialgia is hypofunction of YANG QI in chest; That the heresy of YIN-cold is taken advantage of and send out; Alleviation is intended Gualou Xiebai Banxia Tang, Gualou Xiebai Baijiu Tang, zhishi xiebai guizhi decoction, Aconitum carmichjaelii Debx. Halloysitum Rubrum ball, Ginseng Decoction etc. with the activating stagnated YANG method; Qing Dynasty's Wang Qingren errors in Medicine Corrected is alleviated obstruction of qi in the chest and cardialgia with decoction for removing blood stasis.The traditional Chinese medical science is divided into the deficiency of vital energy, the deficiency of YIN, the stagnation of QI, blood stasis, positive numbness, turbid six types of expectorant with coronary heart disease, and qi-deficiency type coronary disease disease is heavy when light when seeing precordialgia, is main with dull pain; Meet Lao Zefa, spiritlessness and weakness, the lazy speech of breathing hard; The cardiopalmus spontaneous perspiration, dimly pale tongue, corpulent tongue is big; There is indentation on the limit, the thin fur whiten, and weak pulse is unable.Alleviate the compound medicines function singleness of cardiovascular and cerebrovascular disease at present, take effect slowly, and Western medicine can only be taked the way of blood vessel dilating, can only temporaryly alleviate, and cures the symptoms, not the disease, and expensive, make the cardiovascular and cerebrovascular vessel patient be difficult to cure.
Summary of the invention
To above-mentioned situation,, the object of the present invention is to provide a kind of alleviation qi-deficiency type coronary heart disease Chinese medicine oral liquid for overcoming the prior art defective.
The present invention realizes through following technical scheme:
Alleviate qi-deficiency type coronary heart disease Chinese medicine oral liquid, process by the following materials based on weight medicine:
Radix Salviae Miltiorrhizae 200-400 part, Radix Astragali 200-400 part, Folium Ginkgo 100-200 part, Stigma Croci 50-120 part, Semen Cassiae 50-120 part, Rhizoma Pinelliae 100-200 part, Poria 150-200 part, Radix Glycyrrhizae 50-100 part.
Described alleviation qi-deficiency type coronary heart disease Chinese medicine oral liquid, process by the following materials based on weight medicine:
300 parts of Radix Salviae Miltiorrhizaes, 300 parts of the Radixs Astragali, 150 parts of Folium Ginkgos, 100 parts of Stigma Crocis, 150 parts of Semen Cassiaes, 150 parts of the Rhizoma Pinelliaes, 180 parts in Poria, 60 parts in Radix Glycyrrhizae.
The method for preparing of described alleviation qi-deficiency type coronary heart disease Chinese medicine oral liquid comprises the following steps:
1) Semen Cassiae powder is broken into 20 orders, gets 300 parts of the Radixs Astragali, 150 parts of Folium Ginkgos, 150 parts of Semen Cassiaes, 150 parts of the Rhizoma Pinelliaes, 180 parts in Poria, 60 parts of water that add 8 times of Radix Glycyrrhizae, and 60-80 ℃ is soaked continued heating in 30-60 minute down; Intense fire boiling 15 minutes continues to filter with slow fire boiling 40-80 minute; Separate; Get supernatant, be cooled to 30-40 ℃, obtain boiling and carry medicinal liquid A;
2) Radix Salviae Miltiorrhizae powder is broken into 40 orders, gets 300 parts of Radix Salviae Miltiorrhizae powder, 100 parts of water that add 6 times of Stigma Croci, soaks 30-40 minute under the room temperature, and 40-90 ℃ was distilled 50-100 minute, collected distillate, was cooled to 30-40 ℃, obtained the distillate medical liquid B;
3) described boiling put forward medicinal liquid A and described distillate medical liquid B according to volume ratio (1-1.5): l, merges mixing, promptly obtains the Chinese medicine oral liquid of described alleviation qi-deficiency type coronary heart disease.
Method of administration, each 10ml, every day three times.Medicine of the present invention source is abundant, and preparation technology is easy, is easy to carry about with one, and is easy to use, and inexpensive effect is good, has no side effect, and good effect is for vast qi-deficiency type patients with coronary heart disease is removed painful.
Pharmacological action: Radix Salviae Miltiorrhizae: bitter, be slightly cold GUIXIN, pericardium, Liver Channel, blood circulation promoting and blood stasis dispelling, removing heat from blood eliminating carbuncle, nourishing blood to tranquillize the mind; The Radix Astragali: sweet, tepor, return spleen, lung, tonifying Qi and lifting yang, benefit are defended consolidating superficial resistance, promoting pus discharge and tissue regeneration strengthening, inducing diuresis to remove edema; Folium Ginkgo: bitter in the mouth, sweet, puckery, property is flat, mild toxicity, and GUIXIN, lung, spleen channel are invigorated blood circulation and are nourished heart, astringe the lung astringing intestine to stop diarrhea; Stigma Croci: sweet, flat, GUIXIN, Liver Channel, blood circulation promoting and blood stasis dispelling, dispersing stagnation and relieving accumulation of pathogens, removing heat from blood, detoxifcation; Semen Cassiae: sweet, bitter, salty, be slightly cold, return liver, large intestine channel, clearing away heat to improve acuity of vision, loosening bowel to relieve constipation; The Rhizoma Pinelliae: hot, temperature, poisonous, return spleen, stomach, lung meridian, drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass; Poria: sweet, light, flat, GUIXIN, spleen, kidney channel, promoting diuresis to eliminate damp pathogen, spleen invigorating is calmed the nerves; Radix Glycyrrhizae: sweet, flat, GUIXIN, spleen, lung, stomach warp, invigorating the spleen and replenishing QI, nourishing the lung to arrest cough, heat-clearing and toxic substances removing, alleviation pain relieving, the mitigation property of medicine; All medicines match, and controlling QI invigorating to be main, hold concurrently with promoting blood circulation and stopping pain.It is main with dull pain that Chinese medicine oral liquid of the present invention is alleviated qi-deficiency type coronary disease disease rapidly, meets Lao Zefa, spiritlessness and weakness, and the lazy speech of breathing hard, the cardiopalmus spontaneous perspiration, dimly pale tongue, corpulent tongue is big, and there is indentation on the limit, the thin fur whiten, the symptom that weak pulse is unable, specially medicine is specially controlled, and is evident in efficacy.
The specific embodiment
EXAMPLE l:
Crude drug: 300 parts of Radix Salviae Miltiorrhizaes, 300 parts of the Radixs Astragali, 150 parts of Folium Ginkgos, 100 parts of Stigma Crocis, 150 parts of Semen Cassiaes, 150 parts of the Rhizoma Pinelliaes, 180 parts in Poria, 60 parts in Radix Glycyrrhizae.
Preparation: 1) Semen Cassiae powder is broken into 20 orders, gets 300 parts of the Radixs Astragali, 150 parts of Folium Ginkgos, 150 parts of Semen Cassiaes, 150 parts of the Rhizoma Pinelliaes, 180 parts in Poria, 60 parts of water that add 8 times of Radix Glycyrrhizae, and 60-80 ℃ is soaked continued heating in 30-60 minute down; Intense fire boiling 15 minutes continues to filter with slow fire boiling 40-80 minute; Separate; Get supernatant, be cooled to 30-40 ℃, obtain boiling and carry medicinal liquid A;
2) Radix Salviae Miltiorrhizae powder is broken into 40 orders, gets 300 parts of Radix Salviae Miltiorrhizae powder, 100 parts of water that add 6 times of Stigma Croci, soaks 30-40 minute under the room temperature, and 40-90 ℃ was distilled 50-100 minute, collected distillate, was cooled to 30-40 ℃, obtained the distillate medical liquid B;
3) described boiling put forward medicinal liquid A and described distillate medical liquid B according to volume ratio (1-1.5): l, merges mixing, promptly obtains the Chinese medicine oral liquid of described alleviation qi-deficiency type coronary heart disease.Method of administration, each 10ml, every day three times.
Embodiment 2:
Crude drug: 400 parts of Radix Salviae Miltiorrhizaes, 400 parts of the Radixs Astragali, 200 parts of Folium Ginkgos, 120 parts of Stigma Crocis, 120 parts of Semen Cassiaes, 200 parts of the Rhizoma Pinelliaes, 200 parts in Poria, 100 parts in Radix Glycyrrhizae.
Preparation: 1) Semen Cassiae powder is broken into 20 orders, gets 400 parts of the Radixs Astragali, 200 parts of Folium Ginkgos, 120 parts of Semen Cassiaes, 200 parts of the Rhizoma Pinelliaes, 200 parts in Poria, 100 parts of water that add 8 times of Radix Glycyrrhizae, and 60-80 ℃ is soaked continued heating in 30-60 minute down; Intense fire boiling 15 minutes continues to filter with slow fire boiling 40-80 minute; Separate; Get supernatant, be cooled to 30-40 ℃, obtain boiling and carry medicinal liquid A;
2) Radix Salviae Miltiorrhizae powder is broken into 40 orders, gets 400 parts of Radix Salviae Miltiorrhizae powder, 120 parts of water that add 6 times of Stigma Croci, soaks 30-40 minute under the room temperature, and 40-90 ℃ was distilled 50-100 minute, collected distillate, was cooled to 30-40 ℃, obtained the distillate medical liquid B;
3) described boiling put forward medicinal liquid A and described distillate medical liquid B according to volume ratio (1-1.5): l, merges mixing, promptly obtains the Chinese medicine oral liquid of described alleviation qi-deficiency type coronary heart disease.Method of administration, each 10ml, every day three times.
Embodiment 3:
Crude drug: 200 parts of Radix Salviae Miltiorrhizaes, 200 parts of the Radixs Astragali, 100 parts of Folium Ginkgos, 50 parts of Stigma Crocis, 50 parts of Semen Cassiaes, 100 parts of the Rhizoma Pinelliaes, 150 parts in Poria, 50 parts in Radix Glycyrrhizae.
Preparation: 1) Semen Cassiae powder is broken into 20 orders, gets 200 parts of the Radixs Astragali, 100 parts of Folium Ginkgos, 50 parts of Semen Cassiaes, 100 parts of the Rhizoma Pinelliaes, 150 parts in Poria, 50 parts of water that add 8 times of Radix Glycyrrhizae, and 60-80 ℃ is soaked continued heating in 30-60 minute down; Intense fire boiling 15 minutes continues to filter with slow fire boiling 40-80 minute; Separate; Get supernatant, be cooled to 30-40 ℃, obtain boiling and carry medicinal liquid A;
2) Radix Salviae Miltiorrhizae powder is broken into 40 orders, gets 200 parts of Radix Salviae Miltiorrhizae powder, 50 parts of water that add 6 times of Stigma Croci, soaks 30-40 minute under the room temperature, and 40-90 ℃ was distilled 50-100 minute, collected distillate, was cooled to 30-40 ℃, obtained the distillate medical liquid B;
3) described boiling put forward medicinal liquid A and described distillate medical liquid B according to volume ratio (1-1.5): l, merges mixing, promptly obtains the Chinese medicine oral liquid of described alleviation qi-deficiency type coronary heart disease.Method of administration, each 10ml, every day three times.
Embodiment 4:
(1) clinical observation: the clinical remission to 100 routine coronary heart disease and patient with angina pectoris is observed; Age 55 was by 79 years old; Clinical symptoms: uncomfortable in chest, feel suffocated, angina pectoris; Through clothes Chinese medicine of the present invention, 12 hours by having palpitation of causing of coronary heart disease, breathe hard, symptom such as uncomfortable in chest obviously alleviates, anginal symptom is improved rapidly.
(2) Therapeutic Method: with embodiment 1 made Chinese medicine oral liquid, every day early, middle and late respectively taking once, ampoule 10ml, 10 days one courses of treatment.
(3) treatment standard: recovery from illness: symptom complete obiteration; Effectively: symptom disappears basically or alleviates; Invalid: symptom does not have change or deterioration person.
(4) therapeutic outcome: the back of taking medicine is many obviously to alleviate 3-10 days symptoms, and blood pressure stabilization is taken 1-2 the course of treatment, and symptom disappears basically.Cure 1-2 the course of treatment, patient's rehabilitation, and clinical remission 100 examples are wherein cured 90 examples, effective 5 examples, invalid 5 examples, total effective rate is 95%.
Embodiment 5:
Model case: together certain, the man, 57 years old, suffer from coronary heart disease, show as epigastrium pain, normal and celiac disease is obscured.With low grade fever, hyperhidrosis and cold sweat are felt sick, cardiopalmus, and dizziness, weak, take oral liquid of the present invention every day 3 times, each 10ml, above disease was alleviated in 5 days, eliminated in 30 days, recovered normal.
Embodiment 6:
Model case: grandson, the woman, 78 years old, suffer from coronary heart disease, angina pectoris, gas is tight, and edema is weak, and arrhythmia is taken oral liquid of the present invention every day 3 times, each 10ml, above disease was alleviated in 7 days, eliminated in 30 days, recovered normal.
Embodiment 7:
Model case: distinguish certain, the man 67 years old, suffers from coronary heart disease; Show as gas tight, faint, weak, feel sick, vomiting, the violent constriction of the persistence of irregularly showing effect, oral medicine of the present invention, each 10ml; Every day 3 times, above disease was alleviated in 10 days, eliminated in 30 days, and it is normal that life recovers.
Claims (3)
1. alleviate qi-deficiency type coronary heart disease Chinese medicine oral liquid, it is characterized in that: process by the following materials based on weight medicine:
Radix Salviae Miltiorrhizae 200-400 part, Radix Astragali 200-400 part, Folium Ginkgo 100-200 part, Stigma Croci 50-120 part, Semen Cassiae 50-120 part, Rhizoma Pinelliae 100-200 part, Poria 150-200 part, Radix Glycyrrhizae 50-100 part.
2. according to the described alleviation qi-deficiency type of claim l coronary heart disease Chinese medicine oral liquid, it is characterized in that: process by the following materials based on weight medicine:
300 parts of Radix Salviae Miltiorrhizaes, 300 parts of the Radixs Astragali, 150 parts of Folium Ginkgos, 100 parts of Stigma Crocis, 150 parts of Semen Cassiaes, 150 parts of the Rhizoma Pinelliaes, 180 parts in Poria, 60 parts in Radix Glycyrrhizae.
3. according to the method for preparing of the described alleviation qi-deficiency type of claim l coronary heart disease Chinese medicine oral liquid, it is characterized in that: comprise the following steps:
1) Semen Cassiae powder is broken into 20 orders, gets 300 parts of the Radixs Astragali, 150 parts of Folium Ginkgos, 150 parts of Semen Cassiaes, 150 parts of the Rhizoma Pinelliaes, 180 parts in Poria, 60 parts of water that add 8 times of Radix Glycyrrhizae, and 60-80 ℃ is soaked continued heating in 30-60 minute down; Intense fire boiling 15 minutes continues to filter with slow fire boiling 40-80 minute; Separate; Get supernatant, be cooled to 30-40 ℃, obtain boiling and carry medicinal liquid A;
2) Radix Salviae Miltiorrhizae powder is broken into 40 orders, gets 300 parts of Radix Salviae Miltiorrhizae powder, 100 parts of water that add 6 times of Stigma Croci, soaks 30-40 minute under the room temperature, and 40-90 ℃ was distilled 50-100 minute, collected distillate, was cooled to 30-40 ℃, obtained the distillate medical liquid B;
3) described boiling put forward medicinal liquid A and described distillate medical liquid B according to volume ratio (1-1.5): l, merges mixing, promptly obtains the Chinese medicine oral liquid of described alleviation qi-deficiency type coronary heart disease.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210208656.3A CN102688356B (en) | 2012-06-19 | 2012-06-19 | Traditional Chinese medicine oral liquid for easing Qi-deficiency type coronary disease and preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210208656.3A CN102688356B (en) | 2012-06-19 | 2012-06-19 | Traditional Chinese medicine oral liquid for easing Qi-deficiency type coronary disease and preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102688356A true CN102688356A (en) | 2012-09-26 |
| CN102688356B CN102688356B (en) | 2014-03-12 |
Family
ID=46854200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210208656.3A Expired - Fee Related CN102688356B (en) | 2012-06-19 | 2012-06-19 | Traditional Chinese medicine oral liquid for easing Qi-deficiency type coronary disease and preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102688356B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114762703A (en) * | 2021-02-05 | 2022-07-19 | 天津华泰森淼超高压装备工程技术有限公司 | Ultrahigh pressure concentrated oral liquid of white flower and red sage root and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1509732A (en) * | 2002-12-20 | 2004-07-07 | 于忠学 | Chinese medicine for treating coronary disease |
| CN101011562A (en) * | 2006-11-09 | 2007-08-08 | 黄达驹 | Novel formulation of shenqiwendan decoction and production method thereof |
| CN101041019A (en) * | 2006-03-24 | 2007-09-26 | 广州中医药大学第二附属医院 | Traditional Chinese medicinal composition for treating coronary disease and its prepn. method |
| CN101095899A (en) * | 2007-06-29 | 2008-01-02 | 战树森 | Chinese herb medicine for treating coronary heart disease |
| CN102139025A (en) * | 2010-02-03 | 2011-08-03 | 北京阜康仁生物制药科技有限公司 | Chinese medicinal preparation for treating coronary disease and preparation method thereof |
-
2012
- 2012-06-19 CN CN201210208656.3A patent/CN102688356B/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1509732A (en) * | 2002-12-20 | 2004-07-07 | 于忠学 | Chinese medicine for treating coronary disease |
| CN101041019A (en) * | 2006-03-24 | 2007-09-26 | 广州中医药大学第二附属医院 | Traditional Chinese medicinal composition for treating coronary disease and its prepn. method |
| CN101011562A (en) * | 2006-11-09 | 2007-08-08 | 黄达驹 | Novel formulation of shenqiwendan decoction and production method thereof |
| CN101095899A (en) * | 2007-06-29 | 2008-01-02 | 战树森 | Chinese herb medicine for treating coronary heart disease |
| CN102139025A (en) * | 2010-02-03 | 2011-08-03 | 北京阜康仁生物制药科技有限公司 | Chinese medicinal preparation for treating coronary disease and preparation method thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114762703A (en) * | 2021-02-05 | 2022-07-19 | 天津华泰森淼超高压装备工程技术有限公司 | Ultrahigh pressure concentrated oral liquid of white flower and red sage root and preparation method thereof |
| CN114762703B (en) * | 2021-02-05 | 2024-03-22 | 天津华泰森淼超高压装备工程技术有限公司 | Ultra-high pressure white flower red sage root concentrated oral liquid and its preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102688356B (en) | 2014-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103768523A (en) | Chinese herbal medicine compound preparation for treating malignant tumors and preparation method of compound preparation | |
| CN103316249B (en) | Astragalus taxus chinensis capsule and preparing process thereof | |
| CN101683417A (en) | Traditional Chinese medicine composition with function of warming yang and gore removing | |
| CN104001035A (en) | Trichosanthis Radix and Radix Puerariae-containing traditional Chinese medicinal preparation for treating type 2 diabetes mellitus | |
| CN102488874A (en) | Method for preparing bupleurum and cassia twig freeze-dried oral preparation | |
| CN105535390A (en) | Traditional Chinese medicine decoction for treating coronary heart disease and preparation method of traditional Chinese medicine decoction | |
| CN101468148B (en) | Chinese medicinal composition for treating coronary heart disease and cerebral arteriosclerosis, and method for preparing the same | |
| CN104547778A (en) | Traditional Chinese medicine preparation for radiation protection in ultrasound department and preparation method of traditional Chinese medicine preparation | |
| CN102133288B (en) | Chinese herbal preparation for curing angina | |
| CN1049827C (en) | Anti-cancer powder | |
| CN102688356B (en) | Traditional Chinese medicine oral liquid for easing Qi-deficiency type coronary disease and preparation method | |
| CN104606561A (en) | Traditional Chinese medicinal composition for treating spontaneous perspiration | |
| CN101953986B (en) | Method for preparing Chinese medicinal preparation for treating Qi deficiency and blood deficiency | |
| CN103656498A (en) | Traditional Chinese medicine composition for treating coronary heart diseases | |
| CN104548012A (en) | Traditional Chinese medicine composition for treating amyloid cardiomyopathy | |
| CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
| CN103800675A (en) | Traditional Chinese medicine for treating hypertension and preparation method of traditional Chinese medicine | |
| CN103520647B (en) | A kind of adjustment hyperlipidemia Chinese medicine preparation | |
| CN103550745B (en) | Traditional Chinese medicine composition for treating hypotension and preparation method of traditional Chinese medicine composition for treating hypotension | |
| CN102772723A (en) | Chinese medicinal prescription for treating phthisis | |
| CN102743578B (en) | Traditional Chinese medicine preparation for promoting blood circulation to remove meridian obstruction | |
| CN103417920A (en) | Traditional Chinese medicine formula for treating interstitial pneumonia | |
| CN102309650B (en) | Traditional Chinese medicinal composition for regulating menstruation | |
| CN105267862A (en) | Traditional Chinese medicine composition for treating ventricular premature beat | |
| CN105623981A (en) | Benefiting life-prolonging medicinal liquor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: YIN ZHULIANG Free format text: FORMER OWNER: HUANG YUN Effective date: 20140508 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 523120 DONGGUAN, GUANGDONG PROVINCE TO: 523000 DONGGUAN, GUANGDONG PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20140508 Address after: 523000 Guangdong city of Dongguan province Dongcheng District Dongcheng style pedestrian street A elegant department Patentee after: Yin Zhuliang Address before: 523120 A elegant department store, Dongcheng style walking street, Dongguan, Dongcheng District, Guangdong Patentee before: Huang Yun |
|
| CB03 | Change of inventor or designer information |
Inventor after: Li Wenjuan Inventor before: Huang Yun |
|
| CB03 | Change of inventor or designer information | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170731 Address after: 454550, No. 9, Bayi Road, Qin Huai office, Jiaozuo, Henan, Qinyang Patentee after: Li Wenjuan Address before: 523000 Guangdong city of Dongguan province Dongcheng District Dongcheng style pedestrian street A elegant department Patentee before: Yin Zhuliang |
|
| TR01 | Transfer of patent right | ||
| CP02 | Change in the address of a patent holder |
Address after: 225300 15 Ring Road, Diao Pu street, Gao Gang District, Taizhou, Jiangsu Patentee after: Li Wenjuan Address before: 454550 No. 9 Bayi Road, Qinyang, Jiaozuo, Henan Province Patentee before: Li Wenjuan |
|
| CP02 | Change in the address of a patent holder | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140312 Termination date: 20180619 |